Clinical Trials Logo
  1. Home
  2. Renal Replacement Therapy
  3. NCT03636464

Pharmacokinetics of Antibiotics in Patients Undergoing Renal Replacement Therapies — RRTdose  

Renal Replacement Therapy Clinical Trial

Official title:
Pharmacokinetics and Deposition of Commonly Prescribed Antibiotics in Hospitalized Critically Ill Patients Undergoing Renal Replacement Therapies

Clinical Trial Summary

The study is aiming to describe the pharmacokinetic and pharmacodynamic profile of intravenous meropenem, ertapenem, cefepime, colistin, Ceftazidime/Avibactam , Ceftolozane/Tazobactam , and piperacillin/tazobactam in the plasma and determine how much is removed by Renal Replacement Therapies to ensure adequate dosing

Clinical Trial Description

This pharmacokinetic evaluation and clinical outcomes will be an open-label study of 12-16 adult patients/antibiotic dose/modality to a total number of 180-240 patients, admitted to the acute care levels or intensive care unit at Cleveland Clinic Abu Dhabi receiving RRT and prescribed these seven antibiotics as recommended by their treating physicians. The collection of blood, ultrafiltrate or effluent fluids depending on RRT modality (HD or CRRT), and urine samples will begin after participants are administered first dose to determine if a loading dose will be required then after at least three doses (as prescribed by the treating physician) once these drugs will be at steady-state concentration. The study intervention duration will depend on dialysis modality expected to be 3 to 5 days depending on RRT modality and patients will be followed for outcomes (death or cure). Collected blood, effluent and urine samples will be assayed for drug concentration. The concentration data will be modeled by a computer program to determine the pharmacokinetic parameters used to predict future dosing in the case of RRT. Linear/logistic regression will be used as a component of statistical analysis to model the relationship between CRRT machine settings and the amount of the study drugs that will be removed by the filter. Information related to adverse events , clinical and microbiological cure will be collected in case report forms. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT03636464
Study type Observational
Source Cleveland Clinic Abu Dhabi
Contact Wasim El Nekidy, PharmD
Phone +971 2 6590200
Email ElnekiW@ClevelandClinicAbuDhabi.ae
Status Recruiting
Phase
Start date April 1, 2018
Completion date July 1, 2026
View Details
See also
  Status Clinical Trial Phase
Completed NCT04977687 - Machine Learning Predict Renal Replacement Therapy After Cardiac Surgery
Active, not recruiting NCT04132492 - AGNES - Aging Nephropathy Study, a Prospective Observational Cohort of Chronic Kidney Disease in Elderly Patients
Recruiting NCT03302624 - Follow-up of Long-term Renal Function After Acute Kidney Injury in ICU N/A
Completed NCT02590575 - "Low Flow" CO2 Removal on RRT N/A
Not yet recruiting NCT05602129 - A Clinical Study to Evaluate the Efficacy, Safety and PK/PD Profiles of Anticoagulation of HSK36273 for Injection in Continuous Renal Replacement Therapy Subjects Phase 2
Enrolling by invitation NCT01023893 - Blood Viscosity, End-Stage Renal Disease, And Mortality (BEAM-1) N/A
Recruiting NCT04705896 - Albumin To Enhance Recovery After Acute Kidney Injury Phase 4
Completed NCT04203784 - Meropenem and Piperacillin Plasma Concentrations During CRRT
Completed NCT00649298 - A Clinical Trial of IntensiVE Dialysis Phase 4
Completed NCT00484354 - Use of Bicarbonate to Reduce the Incidence of Acute Renal Failure After Cardiac Surgery Phase 2
Completed NCT01877499 - Can High Convection Volumes be Achieved in Each Patient During Online Post-dilution Hemodiafiltration? N/A
Completed NCT03665311 - Saline Versus Albumin Fluid for Extracorporeal Removal With Slow Low Efficiency Dialysis Feasibility Study Phase 2
Completed NCT02341885 - PrEvalence of Acute and Chronic Kidney Disease Treated by Renal Replacement Therapy N/A
Completed NCT04393428 - Urinary Biomarkers for AKI Diagnosis in Patients With SARS-CoV-2 (COVID-19)
Active, not recruiting NCT05646615 - Experiences and Health-related Quality of Life of Informal Caregivers of Dialysis Patients
Completed NCT00906555 - The Effect of Different Dosages of Solute Clearance on Outcome in Twice Weekly Hemodialysis Patients Phase 4
Recruiting NCT06226441 - Aminoglycoside Administration in Septic Patients N/A
Recruiting NCT03632538 - AKI Cardiosurgery Diagnostic Study (AKI-CDS)
Completed NCT01099189 - Vein Histology in Arteriovenous Fistulas and Its Effect on Fistula Surgery Success
Recruiting NCT00980317 - A Clinical Study of the Living Renal Transplantation With Restored Kidneys Between Third Parties N/A